— Know what they know.
Not Investment Advice
Also trades as: AB.PA (PAR) · $vol 0M · 0Q77.L (LSE) · $vol 0M

ABSCF Earnings

AB Science S.A.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -22.8% 1Y: -11.1% 3Y: -84.5% 5Y: -91.2%
$1.12
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Strong Sell · Power 40 · $82.0M mcap · 66M float · 0.0000% daily turnover · Short 100% of daily vol
Last Earnings 2026-05-13
EPS
€-0.08 (US$-0.09)
▲ Beat +0.0%
Revenue
€587K ($661K)
▲ Beat +0.0%
Next Earnings 2026-10-09
EPS Estimate
€-0.08 (US$-0.09)
Revenue Estimate
€685K ($771K)
1 USD = 0.89 EUR

Estimate vs Actual

Earnings Surprise History

2/19
EPS Beats
1/19
Revenue Beats
11%
EPS Beat Rate
5%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-10-02 annual 2026-12-31 €-0.14 €-0.14 — €1,156,992 €1,147,820
2026-10-02 annual 2027-12-31 €-0.13 €-0.13 — €1,253,408 €1,243,472
2026-10-01 annual 2026-12-31 €-0.15 €-0.14 ▲ 0.01 €1,161,077 €1,156,992
2026-10-01 annual 2027-12-31 €-0.14 €-0.13 ▲ 0.01 €1,257,833 €1,253,408
2026-09-29 annual 2026-12-31 €-0.15 €-0.15 — €1,163,171 €1,161,077
2026-09-29 annual 2027-12-31 €-0.14 €-0.14 — €1,260,102 €1,257,833
2026-09-28 annual 2026-12-31 €-0.15 €-0.15 — €1,161,904 €1,163,171
2026-09-28 annual 2027-12-31 €-0.14 €-0.14 — €1,258,730 €1,260,102
2026-09-25 annual 2026-12-31 €-0.15 €-0.15 — €1,172,138 €1,161,904
2026-09-25 annual 2027-12-31 €-0.14 €-0.14 — €1,269,816 €1,258,730
2026-09-21 annual 2026-12-31 €-0.15 €-0.15 — €1,179,379 €1,172,138
2026-09-21 annual 2027-12-31 €-0.14 €-0.14 — €1,277,661 €1,269,816
2026-09-15 annual 2026-12-31 €-0.15 €-0.15 — €1,184,322 €1,179,379
2026-09-15 annual 2027-12-31 €-0.14 €-0.14 — €1,283,016 €1,277,661
2026-09-14 annual 2026-12-31 €-0.15 €-0.15 — €1,185,609 €1,184,322
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms